HIG
TEVA icon

Heritage Investment Group’s Teva Pharmaceuticals TEVA Stock Holding History

Heritage Investment Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$812K Hold
23,975
– – 0.11% 56
2026
Q1 		$722K Hold
23,975
– – 0.11% 58
2025
Q4 		$748K Hold
23,975
– – 0.11% 56
2025
Q3 		$484K Hold
23,975
– – 0.08% 76
2025
Q2 		$402K Hold
23,975
– – 0.07% 78
2025
Q1 		$368K Hold
23,975
– – 0.07% 76
2024
Q4 		$528K Hold
23,975
– – 0.1% 57
2024
Q3 		$432K Hold
23,975
– – 0.08% 64
2024
Q2 		$390K Hold
23,975
– – 0.08% 61
2024
Q1 		$338K Hold
23,975
– – 0.07% 73
2023
Q4 		$250K Hold
23,975
– – 0.06% 83
2023
Q3 		$245K Hold
23,975
– – 0.07% 82
2023
Q2 		$181K Hold
23,975
– – 0.05% 89
2023
Q1 		$212K Hold
23,975
– – 0.06% 78
2022
Q4 		$219K Hold
23,975
– – 0.07% 70
2022
Q3 		$193K Hold
23,975
– – 0.12% 73
2022
Q2 		$180K Hold
23,975
– – 0.1% 80
2022
Q1 		$225K Hold
23,975
– – 0.16% 80
2021
Q4 		$192K Buy
+23,975
New +$216K 0.15% 76

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Heritage Investment Group's TEVA Position: Q2 2026 in Review

Heritage Investment Group held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 23,975 shares worth $812K. The position accounts for 0.11% of the portfolio, ranked #56.

Heritage Investment Group first reported a position in TEVA in Q4 2021 and has held it in 19 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Heritage Investment Group held 23,975 shares of Teva Pharmaceuticals worth $812K as of Q2 2026.
  • Heritage Investment Group left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up 0.11% of Heritage Investment Group's portfolio in Q2 2026, its #56 holding.
  • Heritage Investment Group first reported a position in Teva Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Heritage Investment Group's 13F filing for Q2 2026, filed 29 Jul 2026.